Biomarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc. is a leading global biotechnology company that specializes in developing and commercializing innovative therapies for patients suffering from rare genetic diseases. With a strong focus on rare diseases, BioMarin has built a robust portfolio of products that cater to unmet medical needs and significantly improve the lives of patients. The company's products are designed to treat a wide range of rare genetic diseases, including hemophilia, phenylketonuria, and lysosomal storage disorders. BioMarin is dedicated to advancing the science of rare diseases and has a promising pipeline of potential new therapies in development. Headquartered in San Rafael, California, BioMarin operates in the United States, Europe, Latin America, and Asia-Pacific. The company is committed to making a meaningful difference in the lives of patients and their families, driven by a passion for innovation and a commitment to excellence in everything it does.